In response to the FDA chief, the company will shortly approve Pfizer’s Covid vaccine for an emergency
A Pfizer / BioNTech COVID-19 vaccine vial is expected to be administered on December 8, 2020 at the Royal Victoria Hospital in Belfast, Northern Ireland.
Liam McBurney | Pool | Reuters
The US Food and Drug Administration is “working fast” to clear Pfizer’s Covid-19 vaccine for emergency use after a key panel overwhelmingly approved the shots on Thursday evening, Commissioner Stephen Hahn said in a statement Friday.
“Following yesterday’s positive outcome from the Pfizer-BioNTech COVID-19 vaccine meeting of the Advisory Committee, the US Food and Drug Administration has informed the sponsor that it will work swiftly towards completion and emergency approval “said Hahn in a statement.
“The agency has also notified the US Centers for Disease Control and Prevention and Operation Warp Speed so that they can implement their plans for a timely distribution of the vaccine,” he said.
Hahn’s comments come from the FDA’s Advisory Committee on Vaccines and Related Biological Products on Thursday by 17 votes to 4, with one abstention, in recommending the vaccine, which the company developed with BioNTech, for emergency approval.
This is a developing story. Please try again later.
Comments are closed.